Stock comparison
ELI LILLY & Co is 551.6x more valuable than Aurinia Pharmaceuticals Inc. by market capitalization ($1.119 T vs $2.03 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
LLY is larger
ELI LILLY & Co is 551.6x more valuable than Aurinia Pharmaceuticals Inc. by market capitalization ($1.119 T vs $2.03 B).
Market value leader
LLY
ELI LILLY & Co is 551.6x more valuable than Aurinia Pharmaceuticals Inc. by market capitalization ($1.119 T vs $2.03 B).
Revenue leader
LLY
AUPH: $283.06M vs LLY: $65.18B.
Profit leader
LLY
AUPH: $287.20M vs LLY: $20.64B.
Margin leader
AUPH
AUPH: 101.5% vs LLY: 31.7% net margin.
| Metric | AUPH | LLY |
|---|---|---|
| Market cap | $2.03 B | $1.119 T |
| US-listed rank | #2119 | #10 |
| Revenue (latest FY) | $283.06M | $65.18B |
| Net income (latest FY) | $287.20M | $20.64B |
| Net margin | 101.5% | 31.7% |
| P/E (trailing FY) | 7.1x | 54.2x |
| SEC filings | 595 | 1,000 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
ELI LILLY & Co is 551.6x more valuable than Aurinia Pharmaceuticals Inc. by market capitalization ($1.119 T vs $2.03 B).
In their latest fiscal years, Aurinia Pharmaceuticals Inc. reported $283.06M in revenue while ELI LILLY & Co reported $65.18B.
Full pages: Aurinia Pharmaceuticals Inc. and ELI LILLY & Co, or browse the full rankings.